Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities

SIMPLE SUMMARY: CAR T-cell therapy became standard of care for patients with relapsed or refractory large B-cell lymphoma. However, their administration can be accompanied by toxicities, such as cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome. It is important to...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boer, Janneke W., Keijzer, Kylie, Pennings, Elise R. A., van Doesum, Jaap A., Spanjaart, Anne M., Jak, Margot, Mutsaers, Pim G. N. J., van Dorp, Suzanne, Vermaat, Joost S. P., van der Poel, Marjolein W. M., van Dijk, Lisanne V., Kersten, Marie José, Niezink, Anne G. H., van Meerten, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670876/
https://www.ncbi.nlm.nih.gov/pubmed/38001703
http://dx.doi.org/10.3390/cancers15225443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670876/
https://www.ncbi.nlm.nih.gov/pubmed/38001703
http://dx.doi.org/10.3390/cancers15225443

Ejemplares similares